MiR-122 expression is lower in CD133+ HCC cells, and its overexpression inhibits their stem cell-like characteristics through PDK4 targeting and metabolic reprogramming, demonstrating its central role in the regulation of tumor cell metabolism and stemness properties [70]. This evidence concerns the gene PROM1 and hepatocellular carcinoma.